| Absorption | 
      | Blood-Brain Barrier | BBB+ | 0.9758 | 
      | Human Intestinal Absorption | HIA+ | 0.9913 | 
      | Caco-2 Permeability | Caco2+ | 0.7372 | 
      | P-glycoprotein Substrate | Non-substrate | 0.8956 | 
      | P-glycoprotein Inhibitor | Non-inhibitor | 0.9765 | 
                                                     | Non-inhibitor | 0.9903 | 
      | Renal Organic Cation Transporter | Non-inhibitor | 0.9215 | 
        
            | Distribution | 
        
      | Subcellular localization | Lysosome | 0.5942 | 
        
          | Metabolism | 
        
      | CYP450 2C9 Substrate | Non-substrate | 0.8443 | 
      | CYP450 2D6 Substrate | Non-substrate | 0.8344 | 
      | CYP450 3A4 Substrate | Non-substrate | 0.8266 | 
      | CYP450 1A2 Inhibitor | Non-inhibitor | 0.8598 | 
      | CYP450 2C9 Inhibitor | Non-inhibitor | 0.8992 | 
        | CYP450 2D6 Inhibitor | Non-inhibitor | 0.9686 | 
      | CYP450 2C19 Inhibitor | Non-inhibitor | 0.9331 | 
      | CYP450 3A4 Inhibitor | Non-inhibitor | 0.9853 | 
      | CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.7956 | 
        
          | Excretion | 
        
        
          | Toxicity | 
        
      | Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9638 | 
                                                                    | Non-inhibitor | 0.9738 | 
      | AMES Toxicity | Non AMES toxic | 0.9470 | 
      | Carcinogens | Carcinogens  | 0.6471 | 
      | Fish Toxicity | High FHMT | 0.6004 | 
      | Tetrahymena Pyriformis Toxicity | Low TPT | 0.5333 | 
      | Honey Bee Toxicity | High HBT | 0.8726 | 
      | Biodegradation | Not ready biodegradable | 0.7810 | 
      | Acute Oral Toxicity | III | 0.5765 | 
      | Carcinogenicity (Three-class) | Non-required | 0.5045 |